Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001567619-21-016927 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-09 | 2021-09-07+ | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $6.85 | +11.5K | 85.9K | +15% | +$78.8K |
| DM | 2021-09-09 | 2021-09-07+ | IDYA | Dillon Michael P. | SVP, CSO | S - Sale+OE | $27.42 | -11.5K | 79.0K | -13% | -$315.3K |
| DM | 2021-09-09 | 2021-09-07+ | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $0.00 | -11.5K | 24.9K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | M | A | 116 | $4.31 | 78,905 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-07 | S | D | 116 | $27.46 | 78,789 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $27.45 to $27.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-09-08 | S | D | 200 | $27.67 | 78,789 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-08 | M | A | 4,313 | $11.08 | 90,173 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-08 | S | D | 11,184 | $27.41 | 78,989 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $26.56 to $27.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2021-09-08 | M | A | 7,071 | $4.31 | 85,860 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-09-07 | M | D | 116 | $0.00 | 66,119 | D | $4.31 · — to 2028-02-26 | 116 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-09-08 | M | D | 7,071 | $0.00 | 59,048 | D | $4.31 · — to 2028-02-26 | 7,071 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-09-08 | M | D | 4,313 | $0.00 | 24,937 | D | $11.08 · — to 2029-03-13 | 4,313 Common Stock | (F5) 25% of the shares subject to the option vest on the first anniversary measured from February 19, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |